FIG 1.

Time to surgery by race and treatment sequence among Hispanic and non-Hispanic women with breast cancer, National Cancer Database, 2004-2014. (A) Adjuvant chemotherapy only. (B) Neoadjuvant chemotherapy. Models were adjusted for year of diagnosis, distance traveled for treatment, Charlson-Deyo comorbidity score, education, income, insurance status, facility type, facility location, clinical TNM classifications, grade, histology, estrogen receptor/progesterone receptor status, and surgery type, all of which were significant.